--2025/Q1-- / 21.600M--
--2024/Q4-- / 26.133M--
Nov 6, 20242024/Q325.204M / 24.204M--
Aug 13, 20242024/Q221.848M / 23.963M--
May 13, 20242024/Q118.781M / 21.391M--
US Stock MarketDetailed Quotes
URGN UroGen Pharma Ltd
- 11.350
- -0.120-1.05%
Close Dec 13 16:00 ET
- 11.350
- 0.0000.00%
Post 16:20 ET
478.96MMarket Cap-3.76P/E (TTM)
11.500High11.100Low318.33KVolume11.430Open11.470Pre Close3.60MTurnover0.98%Turnover RatioLossP/E (Static)42.20MShares20.70052wk High18.76P/B367.15MFloat Cap10.60052wk Low--Dividend TTM32.35MShs Float69.568Historical High--Div YieldTTM3.49%Amplitude4.850Historical Low11.303Avg Price1Lot Size
UroGen Pharma Ltd Key Stats
UroGen Pharma Ltd Q3 2024 Earnings Date
Currency：USDNov 6, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 24.20M | 25.20M | +999.71K |
| Beat Est. | +16.08% | +20.87% | +4.13% |
| EPS | -0.81 | -0.55 | +0.26 |
| Beat Est. | -19.86% | +19.12% | +32.51% |
Analyst Rating
Nov 30, 2024
UroGen Pharma Ltd Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
UroGen Pharma Ltd Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Price
% Chg
No Data